Mirtazapine
Mirtazapine
- Mirtazapine is dispensed at pharmacies and is prescription-only in Canada and most jurisdictions; it must be prescribed by a healthcare professional and is not legally available over the counter.
- Mirtazapine is used primarily to treat major depressive disorder and off-label for insomnia, anxiety, appetite stimulation and nausea in palliative care; it is a tetracyclic (NaSSA) antidepressant that increases noradrenergic and serotonergic transmission by antagonising central presynaptic α2‑adrenergic receptors and blocks 5‑HT2/5‑HT3 and H1 receptors (sedative and appetite‑stimulating effects).
- The usual adult dose is 15–45 mg once daily at bedtime (some patients start at 7.5–15 mg for insomnia or frailty); elderly patients and those with hepatic impairment should start at the lower end and titrate cautiously; children and adolescents are not routinely indicated.
- Administered orally as tablets (commonly 7.5, 15, 30, 45 mg), orodispersible tablets (15, 30, 45 mg) and, in some markets, an oral solution; no routine injectable or topical formulations.
- Sedative effects can occur within hours of the first dose; antidepressant benefits often begin after 1–2 weeks, with full response typically taking 4–6 weeks.
- Once‑daily dosing provides effects over 24 hours; the elimination half‑life is roughly 20–40 hours, allowing once‑daily evening dosing.
- Do not combine with alcohol — alcohol increases sedation, impairs cognition and coordination, and raises the risk of respiratory depression and falls.
- The most common side effect is sedation (somnolence); other frequent effects include increased appetite/weight gain, dry mouth, dizziness and constipation.
- Would you like to try “mirtazapine” without a prescription?
Basic Mirtazapine Information
- INN (International Nonproprietary Name): Mirtazapine.
- Brand Names Available In Canada (English): Remeron; Remeron RD; commonly supplied as tablets 7.5 mg, 15 mg, 30 mg, 45 mg.
- ATC Code: N06AX11.
- Forms & Dosages: Tablets 7.5 mg (rare), 15 mg, 30 mg, 45 mg; orodispersible tablets 15 mg, 30 mg, 45 mg; oral solution (not universally available).
- Manufacturers In Canada (English): Organon (originator) and multiple generic suppliers reported globally and used in Canada include Teva, Sandoz, Mylan and Sun Pharma.
- Registration Status In Canada (English): Prescription-only product that is subject to Health Canada labelling and Drug Identification Number (DIN) requirements; confirm DIN and expiry with your pharmacist at dispensing.
- OTC / Rx Classification: Prescription Only (Rx).
Read this before using or prescribing mirtazapine in everyday life: mirtazapine (INN: Mirtazapine) is prescription-only in Canada and will carry a Health Canada Drug Identification Number (DIN) on product labelling; confirm the DIN and expiry with your pharmacist.
Avoid starting or stopping mirtazapine with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI therapy because of serious interaction risk.
If severe drowsiness, breathing difficulty, fainting, chest pain, seizure, or signs of allergic reaction occur, seek emergency care immediately.
Keep tablets stored at 15–30°C in their original packaging and out of reach of children.
Rural patients may need telepharmacy or help navigating provincial coverage such as Ontario Drug Benefit (ODB), BC PharmaCare, or RAMQ.
When switching brands (for example Remeron to a generic by Teva or Sandoz) check with your pharmacist at national chains like Shoppers Drug Mart, Rexall, Jean Coutu, or London Drugs to confirm equivalent strength and formulation.
Prefer a short dispensing checklist: DIN present, dose confirmed, bedtime vs morning plan documented, missed-dose instructions given, and emergency contact provided.
Everyday Use & Best Practices
Morning Vs Evening Dosing In Canadian Routines
Do you wonder whether to take mirtazapine in the morning or at night?
Mirtazapine is typically taken once daily at bedtime because sedation is a common early effect.
Recommended adult dosing range for depression is 15–45 mg once daily at bedtime, with tablet strengths available at 7.5 mg, 15 mg, 30 mg and 45 mg.
For off-label insomnia or appetite stimulation some prescribers start at 7.5–15 mg at night.
Shift workers or those who nap frequently should schedule doses to avoid operating heavy machinery or driving for 24–48 hours after starting or increasing dose until tolerance is known.
Keep a simple medication log noting time taken, sleep duration, and daytime drowsiness to discuss at follow-ups.
- Checklist: DIN checked at dispensing, dose and time documented, missed-dose plan noted, emergency contact included.
Taking With Or Without Meals (Canadian Diet Context)
Does food matter when you take mirtazapine?
Mirtazapine may be taken with or without food.
Heavier evening meals common in some Canadian households, especially high-fat meals, can increase morning grogginess when combined with a sedating dose.
If increased appetite leads to unwanted weight gain, consider smaller evening portions and a nutrition plan discussed with your primary care team.
- Dosing Times: Take at bedtime unless directed otherwise by your prescriber.
- Sleep Hygiene Tips: Keep a regular sleep schedule, reduce late caffeine, and create a dark, quiet bedroom environment.
- Weight-Monitor Actions: Record weight weekly for the first month, and discuss diet or referral to a nutritionist if gain occurs.
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Who should not take mirtazapine?
Do not use mirtazapine if you have known hypersensitivity to mirtazapine or any excipients in the product.
Avoid concurrent MAOI use or starting mirtazapine within 14 days of stopping an MAOI because of serious interaction risk.
Use caution in severe hepatic or renal impairment, in people with a seizure history, uncontrolled bipolar disorder, recent myocardial infarction, or narrow-angle glaucoma.
Elderly adults are at higher risk of sedation and falls and should usually start at lower doses such as 7.5–15 mg with slow titration.
Confirm Health Canada guidance and consult your prescriber or pharmacist before starting; always review the DIN and product labelling at dispensing.
Activities To Limit (Driving, Workplace Safety)
Can you drive after a dose?
Until individual tolerance is established, avoid driving, operating heavy machinery, or safety-sensitive work because mirtazapine can cause sedation and orthostatic hypotension.
Employers and occupational health services in Canada may require documentation for modified duties during dose initiation or increases.
- Safety Checklist After Dose Change: no driving for 24–48 hours, avoid alcohol, monitor blood pressure and dizziness, report persistent severe drowsiness to your pharmacist.
Dosage & Adjustments
General Regimen (DIN References)
What is the usual dosing for adults?
Standard adult dosing for major depressive disorder is 15–45 mg once daily at bedtime.
Off-label starting doses for insomnia or appetite stimulation often begin at 7.5–15 mg at night.
When dispensing in Canada confirm the DIN and formulation, whether film-coated tablet or orodispersible form.
Available strengths include 7.5, 15, 30 and 45 mg tablets and 15, 30, 45 mg orodispersible tablets.
Missed-dose instructions: take as soon as remembered unless it is near the time for the next dose; do not double the next dose.
Special Cases (Elderly, Comorbidities)
How is dosing adjusted for older adults and organ impairment?
| Patient Group | Usual Advice |
|---|---|
| Elderly | Start low (7.5–15 mg), titrate slowly, monitor for sedation, orthostatic hypotension and falls. |
| Hepatic Impairment | Start at lowest dose and titrate slowly due to increased exposure. |
| Severe Renal Impairment | Use with caution and monitor closely; titrate slowly. |
| Children/Adolescents | Not routinely indicated; safety and efficacy not established and specialist review required for off-label use. |
User Testimonials
Positive Reports From Canadian Patients
What do Canadians say about mirtazapine?
Many users report rapid improvement in sleep and an early lift in mood within one to two weeks, especially on 15–30 mg bedtime doses.
Appetite improvement and weight gain are frequently noted and can be beneficial in oncology or palliative settings.
Patients often report good tolerability with fewer sexual side effects compared with many SSRIs.
Commonly mentioned brands in Canada include Remeron and generics by Teva and Sandoz.
Common Challenges In Forums (Reddit Canada, Health Boards)
What do patients commonly struggle with?
Reports on forums frequently mention daytime sedation, weight gain, dry mouth, vivid dreams, and morning grogginess.
Some people need timing adjustments or dose changes to manage sedation or appetite effects.
Rural patients sometimes report delays filling prescriptions and reliance on mail-order pharmacies, and note differences in provincial coverage such as ODB, BC PharmaCare and RAMQ.
- What Patients Say: improved sleep, increased appetite, less sexual dysfunction, variable daytime sedation.
- When To Call Your Provider: severe drowsiness, rapid weight gain, new seizures, fainting or suicidal thoughts.
Buying Guide
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
Where can you pick up mirtazapine in Canada?
Mirtazapine is prescription-only and can be filled at national chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, or at community pharmacies.
Generic supplies commonly come from manufacturers such as Teva, Sandoz, Mylan and Sun Pharma, in addition to the originator Remeron.
Always confirm the DIN at dispensing and ask the pharmacist to name the manufacturer if a brand change is proposed.
Price Comparison (In-Store Vs Online, Cross-Border Notes)
How do prices and access compare?
Prices vary by province and by private or public drug plan, including ODB, BC PharmaCare and RAMQ, and some patients require special authorizations for formulary coverage.
Online pharmacies may offer lower cash prices but verify a Canadian licence and the DIN on the product before purchase.
Cross-border purchasing from the United States can be cheaper but carries risks of different packaging, formulation, or regulatory standards and may require prescriber consent.
In our online pharmacy, mirtazapine is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
| Source | Pros | Cons |
|---|---|---|
| In-Store (Chains) | Immediate pickup, pharmacist counselling, claims processing with provincial plans. | Variable cash price, may require refill wait times. |
| Online Canadian Pharmacies | Convenience, sometimes lower cash price, home delivery. | Confirm licence and DIN; delivery wait times apply. |
| Cross-Border / US | Possible lower price for some brands. | Regulatory differences, packaging differences, potential customs issues. |
- Pre-Purchase Checklist: Confirm DIN, expiry date, manufacturer, formulation and provincial coverage if applicable.
What’s Inside & How It Works
Ingredients Overview
What is in a mirtazapine tablet?
The active ingredient is the international nonproprietary name mirtazapine, in tablet or orodispersible form in strengths of 7.5, 15, 30 and 45 mg.
Excipients vary by manufacturer; check packaging labels for lactose or other components if you have intolerances.
Manufacturers supplying in Canada include Organon and multiple generics such as Teva and Sandoz.
Mechanism Basics
How does mirtazapine work?
Mirtazapine is classified under ATC code N06AX11 as an atypical or tetracyclic antidepressant that increases noradrenergic and serotonergic neurotransmission.
It works primarily by antagonising central presynaptic alpha-2 receptors and blocking 5-HT2 and 5-HT3 serotonin receptors, which explains its sedative and appetite-stimulating effects.
These receptor actions also likely contribute to lower rates of sexual side effects compared with many SSRIs.
| Feature | Detail |
|---|---|
| Active Ingredient | Mirtazapine. |
| ATC Code | N06AX11. |
| Primary Actions | Alpha-2 antagonism; 5-HT2/5-HT3 blockade; noradrenergic and serotonergic enhancement. |
Main Indications
Approved Uses In Canada
What is mirtazapine approved for?
In Canada mirtazapine is indicated for major depressive disorder in adults with standard dosing 15–45 mg once daily at bedtime.
Therapeutic effects on sleep may be seen in one to two weeks, with full mood response often by four to six weeks.
Confirm Health Canada-approved labelling and the DIN at dispensing.
Off-Label Uses By Canadian Physicians
How do doctors use mirtazapine off-label?
Common off-label uses include treating insomnia associated with depression, stimulating appetite in oncology or palliative care, and adjunctive management of anxiety symptoms.
Clinicians typically use lower starting doses of 7.5–15 mg at night for these purposes and document off-label use with informed consent and monitoring.
- Indication Checklist: Documented indication, expected timeline for benefit, and scheduled follow-up visits.
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
What substances should you avoid?
Avoid alcohol while taking mirtazapine because combined central nervous system depression increases sedation and fall risk.
Caffeine may temporarily counteract sedation but can disrupt sleep and is best used cautiously in the evenings.
There are no strict food restrictions, but monitor appetite and weight changes if you alter diet.
Drug Conflicts (Health Canada Database)
What drugs should not be combined with mirtazapine?
Avoid concurrent MAOI therapy or starting mirtazapine within 14 days of MAOI discontinuation due to dangerous interactions.
Use caution with other CNS depressants, opioids, benzodiazepines and other sedating drugs because of additive sedation.
Be alert when combining with serotonergic agents (SSRIs, SNRIs, triptans, certain opioids) where serotonin syndrome is a theoretical risk.
Monitor interactions with drugs that affect cytochrome P450 enzymes and those that increase QT interval or cause orthostatic hypotension.
- High-Risk Drug Classes: MAOIs, opioids, benzodiazepines, SSRIs/SNRIs, certain antipsychotics.
Always check Health Canada resources or ask your pharmacist to run an interaction screen before adding new medicines.
Latest Evidence & Insights
Highlight Canadian And International Research
What does the evidence show?
Randomised trials and meta-analyses show mirtazapine is effective for major depressive disorder and often provides faster relief for sleep symptoms compared with some SSRIs.
Its distinct receptor profile explains both the rapid sleep benefit and lower incidence of sexual side effects.
Canadian guideline commentary emphasises caution in elderly patients and monitoring for weight gain and sedation.
Practical Takeaways For Patients
How should patients track progress?
| Outcome | Timeline | Monitoring Checkpoints |
|---|---|---|
| Sleep | Improvement 1–2 weeks | Sleep diary, daytime drowsiness notes |
| Mood | Partial response by 4–6 weeks, full response may take longer | PHQ-9 or clinician assessment at 4–6 weeks |
| Weight | Possible gain over weeks | Weekly weight checks initially, dietary plan if gain noted |
Typical continuation after remission is six to twelve months to reduce relapse risk.
Bring a concise side-effect log to follow-ups to help your prescriber decide on dose changes.
Alternative Choices
Comparable Medicines With Pros/Cons Checklist
What are reasonable alternatives if mirtazapine is not suitable?
- SSRIs (Sertraline, Escitalopram, Fluoxetine): Generally weight-neutral but more likely to cause sexual side effects.
- SNRIs (Venlafaxine, Duloxetine): Useful for pain and depression but can increase blood pressure or cause more activation in some patients.
- Other Atypicals (Trazodone, Bupropion): Trazodone also sedating; bupropion is activating and can help with energy and sexual side effects but may not help sleep.
When To Consider Switching
When should a prescriber consider a change?
Consider switching for intolerable sedation that impairs function, problematic weight gain, inadequate mood response after an adequate trial of four to six weeks at therapeutic dose, or new safety concerns such as seizures or severe orthostatic hypotension.
Switching strategies such as cross-tapering versus direct switch should be discussed with your prescriber and documented in the chart, and pay attention to provincial formulary coverage differences when choosing a substitute.
Regulation Snapshot
Health Canada Approval And DIN Requirements
How is mirtazapine regulated in Canada?
Mirtazapine is prescription-only and subject to Health Canada approval and DIN labelling; always confirm the DIN at dispensing.
International approvals include FDA, EMA, MHRA and TGA, which support its long-term safety data and global availability.
Provincial Reimbursement & Access (ODB, PharmaCare, RAMQ)
How does public coverage affect access?
Provincial plans differ and may list mirtazapine generics with varying listing criteria, copays and special authorisation requirements.
Pharmacies such as Shoppers, Rexall, Jean Coutu and London Drugs regularly process claims and can advise on substitution policies and therapeutic equivalence.
| Regulatory Status | Provincial Coverage Action |
|---|---|
| Prescription Only; DIN required | Varies by province; check ODB, BC PharmaCare, RAMQ listings and special authorizations. |
FAQ Section
Can I Drive After My First Dose?
No—avoid driving until you know how mirtazapine affects you because sedation can be marked after initiation or dose increases.
Contact your pharmacist if severe drowsiness persists.
Will It Make Me Gain Weight?
Appetite increase and weight gain are common and should be discussed with your prescriber and possibly a nutritionist.
If weight gain is rapid or concerning, consult your clinician for alternatives or dose adjustments.
Can I Drink Alcohol?
Avoid alcohol while taking mirtazapine because of additive sedation and increased fall risk.
Seek emergency care for overdose symptoms such as severe central nervous system depression or seizures.
How Long Until It Works?
Sleep may improve in one to two weeks while mood symptoms often take four to six weeks to show significant benefit.
Call your prescriber if there is no improvement after an adequate trial or if side effects are severe.
- Handy Pharmacy Checklist: Bring this FAQ to the pharmacist: driving risk, weight monitoring, alcohol avoidance, expected timeline for benefit.
Guidelines For Proper Use
Canadian Pharmacist And Provincial Health Authority Recommendations
What should pharmacists counsel on?
Pharmacists should reconcile all medications at each refill and specifically check for current or recent MAOI exposure.
Counsel on bedtime dosing, missed-dose rules, storage at 15–30°C, and to check the DIN and manufacturer when substituting brands.
Provincial authorities recommend lower starting doses for older adults and monitoring for falls, weight gain, blood pressure changes and mood or behaviour alterations.
Tapering, Follow-Up, And Monitoring Checklist
How should stopping or follow-up be handled?
Gradual tapering is recommended to reduce withdrawal and relapse risk after treatment, and typical continuation after remission is six to twelve months.
Suggested follow-up schedule: 1–2 weeks to check tolerance, 4–6 weeks to assess efficacy, then monthly until stable.
- Monitoring Checklist: weight, sleep quality, sedation level, blood pressure/orthostatic symptoms, changes in mood or suicidal ideation.
- Taper Plan Template: reduce dose by small increments over weeks under prescriber supervision rather than stopping abruptly.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Hamilton | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
Closing Notes
If you have questions about a Remeron 30 mg prescription, confirm the DIN and manufacturer with your pharmacy before switching brands.
Keep a short medication and side-effect log to speed clinical decisions at follow-up appointments.
For urgent symptoms such as severe drowsiness, breathing issues, collapse, chest pain or seizures, seek emergency care immediately.
Pharmacists at national chains can help with provincial coverage questions and therapeutic substitutions when needed.